J. Vencovsky

Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint (2007)

VAN LIEROP, MJC, DEN HOED, L, HOUBIERS, J, VENCOVSKY, J, RUZICKOVA, S, KRYSTUFKOVA, O, ...

Citrullinated peptide-specific CD19+B cells are present in synovial tissue and peripheral blood of patients with rheumatoid arthritis (2005)

Ruzickova, S, Cimburek, Z, Moravcova, T, Huzlova, Z, Vesela, I, Niederlova, J, ...

No abstract available.

The importance of cell surface RANKL in rheumatoid arthritis (2005)

Krystufkova, O, Sinkora, J, Jarosova, K, Hladikova, M, Niederlova, J, Rehakova, Z, ...

No abstract available.

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (2005)

Holten, J. Van, Pavelka, K., Vencovsky, J., Stahl, H., Rozman, B., Genovese, M., ...

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (2005)

Holten, J. Van, Pavelka, K., Vencovsky, J., Stahl, H-D., Rozman, B., Genovese, M., ...

Two B cell populations differentially expressing IgVH mRNAs in human RA synovium (2004)

Ruzickova, S, Krystufkova, O, Sedova, L, Niederlova, J, Cimburek, Z, Dörner, T, ...

No abstract available.

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease (2004)

Isenberg, D. A., Allen, E., Farewell, V., Ehrenstein, M. R., Hanna, M. G., Lundberg, I. E., ...

Objective. To devise new tools to assess activity and damage in patients with idiopathic myopathies (IIM). Methods. An international multidisciplinary consensus effort to standardize the conduct and...

OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy (2003)

Krystufkova, O, Niederlova, J, Senolt, V, Hladikova, M, Ruzickova, S, Vencovsky, J

No abstract available.

Differential expression of IgVH mRNAs in human RA synovium detected by single-cell RT-PCR (2003)

Ruzickova, S, Cimburek, Z, Niederlova, J, Horvath, O, Krystufkova, O, Dörner, T, ...

No abstract available.

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease (2003)

Isenberg, D. A., Allen, E., Farewell, V., Ehrenstein, M. R., Hanna, M. G., Lundberg, I. E., ...

Objective. To devise new tools to assess activity and damage in patients with idiopathic inflammatory myopathies (IIM). Methods. An international multidisciplinary consensus effort to standardize the...

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease (2003)

Isenberg, D. A., Allen, E., Farewell, V., Ehrenstein, M. R., Hanna, M. G., Lundberg, I. E., ...

Objective. To devise new tools to assess activity and damage in patients with idiopathic inflammatory myopathies (IIM). Methods. An international multidisciplinary consensus effort to standardize the...

Loss of surface CXCR3 expression in the RA synovial CD3 cells as a result of ligand binding suggests the mechanism for increased Th1 cell infiltration (2002)

Krystufkova, OK, Niederlova, J, Ruzickova, S, Sinkora, J, Rehakova, Z, Horvath, O, ...

No abstract available.

Polymorphism in the immunoglobulin VH gene V1-69 affects susceptibility to rheumatoid arthritis in subjects lacking the HLA-DRB1 shared epitope (2002)

Vencovsky, J., Zd’ársky, E., Moyes, S. P., Hajeer, A., Ruzicková, S., Cimburek, Z., ...

Objective. To investigate the contribution of polymorphism in the immunoglobulin heavy chain variable region V1‐69 gene set to genetic susceptibility to rheumatoid arthritis (RA)...

Tumour necrosis factor {alpha} G->A -238 and G->A -308 polymorphisms in juvenile idiopathic arthritis (2002)

Ozen, S., Alikasifoglu, M., Bakkaloglu, A., Duzova, A., Jarosova, K., Nemcova, D., ...

Objectives. To study G→A −238 and G→A −308 polymorphisms in the promoter region of the tumour necrosis factor (TNF) α gene in patients with juvenile idiopathic arthritis...

The significance of antibodies to cyclic citrullinated peptide, antikeratin antibodies, anti-perinuclear factor, rheumatoid factor isotypes and HLA shared epitope in prediction of erosive disease in early rheumatoid arthritis patients (2001)

Vencovsky, J, Sedova, L, Machacek, S, Gatterova, J, Pesakova, V, Kafkova, J, ...

No abstract available.

Intracellular expression of CXCR3 on rheumatoid arthritis synovial tissue cells (2001)

Krystufkova, O, Vencovsky, J, Ruzickova, S, Sinkora, J, Niederlova, J, Power, CA, ...

No abstract available.

Analysis of VH and VL mRNA in single synovial and peripheral B/plasma cells of patients with rheumatoid arthritis (2001)

Ruzickova, S, Vencovsky, J, Krystufkova, O, Cimburek, Z, Sinkora, J, Horvath, O, ...

No abstract available.

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies (2001)

Miller, F. W., Rider, L. G., Cooper, R., Danko, K., Farewell, V., ...

In order to develop a preliminary core set of disease outcome measures for use in clinical trials of idiopathic inflammatory myopathies (IIM), we evaluated those measures used in previous...

HETEROGENEITY OF DISEASE PHENOTYPE IN MONOZYGOTIC TWINS CONCORDANT FOR RHEUMATOID ARTHRITIS (1995)

MACGREGOR, A. J., BAMBER, S., CARTHY, D., VENCOVSKY, J., MAGEED, R. A., OLLIER, W. E. R., ...

The objective of the study was to investigate the genetic contribution to the clinical expression of rheumatoid arthritis (RA) by comparison of disease features in RA-concordant monozygotic (MZ) twin...

RHEUMATOID FACTORS AND GERMLINE GENES IN RHEUMATOID ARTHRITIS: EVIDENCE OF AN INTRINSIC B-LYMPHOCYTE DEFECT? (1994)

MAGEED, R. A., VENCOVSKY, J., MAINI, R. N.

Clinical associations of IgG antibodies to the ribonucleoprotein p67 polypeptide in patients with systemic lupus erythematosus.

Vencovsky, J, Williams, D G, Field, M, Maini, R N

The ribonucleoprotein (RNP) p67 antigen was purified from rabbit thymus and used in an enzyme linked immunosorbent assay (ELISA) with low interassay variability to detect IgG antibodies to p67 in...

The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient

Hengstman, G, Van Venrooij, W J, Vencovsky, J, Moutsopoulos, H

Autoantibody profiles in the sera of European patients with myositis

Brouwer, R, Hengstman, G, Egberts, W, Ehrfeld, H, Bozic, B, Ghirardello, A, ...

OBJECTIVE—To determine the prevalence of myositis specific autoantibodies (MSAs) and several myositis associated autoantibodies (MAAs) in a large group of patients with myositis.
METHODS—A...

Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis

Vencovsky, J, Machacek, S, Sedova, L, Kafkova, J, Gatterova, J, Pesakova, V, ...

Objective: To evaluate a contribution of selected laboratory parameters for a prediction of progressive and erosive development in patients with early rheumatoid arthritis (RA).

Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with coeliac disease

Krupickova, S, Tuckova, L, Flegelova, Z, Michalak, M, Walters, J, Whelan, A, ...

a Department of Immunology, Institute of Microbiology, Czech Academy of Sciences, Prague, b Research Institute of Biopharmacy and Veterinary Drugs, Jílové, c Institute of Rheumatology, Prague,...

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

Van Holten, J, Pavelka, K, Vencovsky, J, Stahl, H, Rozman, B, Genovese, M, ...

Objective: To assess the efficacy of interferon beta (IFNß) in combination with methotrexate in treatment of patients with rheumatoid arthritis.

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi‐2β antigen

Hengstman, G J D, Seelig, H P, Lundberg, I E, Moutsopoulos, H M, Doria, A, ...

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

Fleischmann, R, Vencovsky, J, Van Vollenhoven, R F, Borenstein, D, Box, J, Coteur, G, ...